Apr 5, 2021 5:30 PM EDT Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
Apr 5, 2021 4:05 PM EDT Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
Mar 15, 2021 8:05 AM EDT Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
Mar 2, 2021 4:05 PM EST Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
Jan 28, 2021 4:15 PM EST Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
Nov 24, 2020 4:15 PM EST Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Nov 19, 2020 7:50 PM EST Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering